RTOG 0131: Phase II trial of pre-irradiation and concurrent temozolomide in patients with newly diagnosed anaplastic oligodendrogliornas and mixed anaplastic oligodendrogliomas: Relationship between lp/19q status and progression-free survival. Conference

cited authors

  • Vogelbaum, MA; Berkey, B; Peereboom, D; Giannini, C; Jenkins, R; Suh, J; Brown, P; Blumenthal, D; Biggs, C; Mehta, M

fiu authors

publication date

  • June 20, 2006

keywords

  • Life Sciences & Biomedicine
  • Oncology
  • Science & Technology

Location

  • Atlanta, GA

Conference

  • 42nd Annual Meeting of the American-Society-of-Clinical-Oncology

start page

  • 62S

end page

  • 62S

volume

  • 24

issue

  • 18